STOCK TITAN

Augmedix to Report Second Quarter 2022 Financial Results on August 8, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Augmedix, Inc. (Nasdaq: AUGX) announced it will release its second quarter 2022 financial results on August 8, 2022, after market close. A conference call will follow at 1:30 p.m. PT / 4:30 p.m. ET, with access available via phone and webcast. The company specializes in automated medical documentation and data services, aiding healthcare systems and physician practices nationwide through its Ambient Automation Platform. This technology converts physician-patient conversations into structured medical notes, enhancing efficiency and quality in healthcare delivery.

Positive
  • Company specializes in automated medical documentation, addressing administrative burdens for healthcare providers.
  • Ambient Automation Platform improves efficiency by converting conversations into structured medical notes.
Negative
  • None.

SAN FRANCISCO, July 25, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today announced it will report financial results for the second quarter of 2022 on Monday, August 8, 2022, after market close. Company management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Conference Call & Webcast Details
The conference call can be accessed by dialing +1-877-407-3982 for U.S. participants or +1-201-493-6780 for international participants and referencing conference ID # 13730853. Interested parties may access a live and archived webcast of the event on the “Events” section of the Company’s website at: https://ir.augmedix.com/news-events.

About Augmedix

Augmedix, Inc. (Nasdaq: AUGX) provides automated medical documentation and data services to large healthcare systems and physician practices, supporting medical offices, clinics, hospitals, emergency departments, and telemedicine nationwide. The Company’s Ambient Automation Platform converts the natural conversation between physicians and patients into timely and comprehensive medical notes and performs a suite of related data services. These services relieve physicians of administrative burdens to enable more time for patient care. Augmedix’s proprietary platform uses automatic speech recognition, natural language processing and clinical datasets to capture the ambient visit conversation and generate a structured medical note. The structured medical note data is then used to deliver additional data services. Quality is assured by trained medical documentation specialists. To learn more about Augmedix, visit augmedix.com.

Investors:
Caroline Paul
Gilmartin Group
investors@augmedix.com

Media:
Kaila Grafeman
Augmedix
pr@augmedix.com

 


FAQ

What is Augmedix's upcoming financial report date?

Augmedix will report its financial results for Q2 2022 on August 8, 2022.

What time is the Augmedix conference call scheduled?

The conference call is scheduled for 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

How can I access the Augmedix conference call?

You can access the conference call by dialing +1-877-407-3982 for U.S. participants or +1-201-493-6780 for international participants.

Augmedix, Inc.

NASDAQ:AUGX

AUGX Rankings

AUGX Latest News

AUGX Stock Data

116.16M
48.69M
1.5%
84.78%
2.16%
Health Information Services
Services-business Services, Nec
Link
United States of America
SAN FRANCISCO